Inventor · disambiguated record
Mohammad Salman
Also filed as: SALMAN MOHAMMAD · SALMAN MOHAMMAD Y
19 granted patents·45 pending applications·249 citations·filing 1981–2021
94Inventor score
Top patents by PatentIndex Score
64 records- 0196US8239365B2Flexible request and response communications interfacesSALMAN MOHAMMAD·Filed 2010·Granted Aug 7, 2012·79 cites·14 claims
- 0295US9592246B2Tetracycline topical formulations, preparation and uses thereofHOVIONE INT LTD·Filed 2013·Granted Mar 14, 2017·44 cites·35 claims
- 0391US9167095B1Call center agent managementVERIZON PATENT & LICENSING INC·Filed 2014·Granted Oct 20, 2015·29 cites·20 claims
- 0490US4447622APreparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereofCOUNCIL SCIENT IND RES·Filed 1981·Granted May 8, 1984·51 cites·2 claims
- 0586US10213443B2Tetracycline topical formulations, preparation and uses thereof in treating an ocular conditionHOVIONE INT LTD·Filed 2017·Granted Feb 26, 2019·8 cites·20 claims
- 0680US9530116B2Finite state machine-based call manager for web-based call interactionVERIZON PATENT & LICENSING INC·Filed 2013·Granted Dec 27, 2016·3 cites·20 claims
- 0774US6686497B1Synthesis of 3-ethoxy-4-ethoxycarbonyl phenyl acetic acid, a key acid synthon of repaglinideRANBAXY LAB LTD·Filed 2000·Granted Feb 3, 2004·8 cites·18 claims
- 0869US7825147B2Inhibitors of phosphodiesterase type-IVRANBAXY LAB LTD·Filed 2004·Granted Nov 2, 2010·7 cites·6 claims
- 0966US7148355B2Process for the preparation of repaglinideRANBAXY LAB LTD·Filed 2002·Granted Dec 12, 2006·4 cites·10 claims
- 1066US7078430B2HMG CoA-reductase inhibitorsRANBAXY LAB LTD·Filed 2003·Granted Jul 18, 2006·6 cites·66 claims
- 1160US11596641B2Methods and compositions for treating meibomian gland dysfunctionHOVIONE SCIENTIA LTD·Filed 2021·Granted Mar 7, 2023·0 cites·22 claims
- 1258US7592335B2Oxazolidinone derivatives as antimicrobialsRANBAXY LAB LTD·Filed 2006·Granted Sep 22, 2009·1 cites·8 claims
- 1357US7923467B2Substituted pyrrole derivatives and their use as HMG-CO inhibitorsRANBAXY LAB INC·Filed 2004·Granted Apr 12, 2011·2 cites·23 claims
- 1457US7788250B2Flexible request and response communications interfacesSALMAN MOHAMMAD·Filed 2007·Granted Aug 31, 2010·1 cites·16 claims
- 1557US7446123B2Azabicyclo derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2004·Granted Nov 4, 2008·1 cites·2 claims
- 1656US7544708B2Azabicyclo derivatives as muscarinic receptor antagonistsRANBAXY LAB LTD·Filed 2003·Granted Jun 9, 2009·1 cites·7 claims
- 1755US2021308154A1Methods and Compositions for Treating Meibomian Gland DysfunctionHOVIONE SCIENTIA LTD·Filed 2021·Application pending·0 cites
- 1850US2022125829A1Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disordersHOVIONE SCIENTIA LTD·Filed 2021·Application pending·0 cites
- 1949US2022062308A1Methods and compositions for treating rosaceaHOVIONE SCIENTIA LTD·Filed 2021·Application pending·0 cites
- 2048US9681171B2Providing second screen content based on a frequency codeVERIZON PATENT & LICENSING INC·Filed 2014·Granted Jun 13, 2017·0 cites·20 claims
- 2147US6441226B1Process for the preparation of isotretinoinRANBAXY LAB LTD·Filed 1999·Granted Aug 27, 2002·4 cites·9 claims
- 2247US2011190369A1Substituted Pyrrole Derivatives and Their Use as HMG-CO InhibitorsRANBAXY LAB LTD·Filed 2011·Application pending·0 cites
- 2347US2011190296A1Substituted Pyrrole Derivatives and Their Use as HMG-CO InhibitorsRANBAXY LAB LTD·Filed 2011·Application pending·0 cites
- 2446US2010035954A1Acid addition salts of muscarinic receptor antagonistsSALMAN MOHAMMAD·Filed 2004·Application pending·0 cites
- 2545US2007149605A1Substituted pyrrole derivatives as hmg-coa reductase inhibitorsSATTIGERI JITENDRA·Filed 2004·Application pending·0 cites
- 2645US2007021487A1Azabicyclo derivatives as muscarinic receptor antagonistsSALMAN MOHAMMAD·Filed 2004·Application pending·0 cites
- 2743US2007270484A13'-N-Substituted-3-O-Substituted Erythronolide a DerivativesDAS BISWAJIT·Filed 2003·Application pending·0 cites
- 2842US2007219216A11-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor AntagonistsANAND NITYA·Filed 2004·Application pending·0 cites
- 2942US2009221515A1Monosaccharide derivativesSATTIGERI VISWAJANANI JITENDRA·Filed 2005·Application pending·0 cites
- 3041US2009312344A1Arylpiperazine derivatives as adrenergic receptor antagonistsSALMAN MOHAMMAD·Filed 2005·Application pending·0 cites
- 3141US2006247249A1Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockersSALMAN MOHAMMAD·Filed 2005·Application pending·0 cites
- 3240US2008319043A13,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor AntagonistsSALMAN MOHAMMAD·Filed 2006·Application pending·0 cites
- 3340US2009209612A1Process for the preparation of atorvastatinSATTIGERI JITENDRA A·Filed 2005·Application pending·0 cites
- 3440US2008319002A1Xanthine Derivatives a Useful as Muscarinic Receptor AntagonistsRANBAXY LAB LTD·Filed 2004·Application pending·0 cites
- 3539US2009005325A1Ketolide Derivatives as Antibacterial AgentsBAS BISWAJIT·Filed 2006·Application pending·0 cites
- 3639US2009137623A1Muscarinic receptor antagonistsKUMAR NARESH·Filed 2007·Application pending·0 cites
- 3739US2004102511A1Substituted pyrrole derivativesFiled 2003·Application pending·0 cites
- 3838US2010016400A1Azabicyclic muscarinic receptor antagonistsKUMAR NARESH·Filed 2005·Application pending·0 cites
- 3938US2009170790A1Ketolide derivatives as antibacterial agentsDAS BISWAJIT·Filed 2005·Application pending·0 cites
- 4038US2009048186A1Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer AgentsSATTIGERI VISHWAJANANI JITENDRA·Filed 2005·Application pending·0 cites
- 4138US2004242896A1Azole compounds as anti-fungal agentsFiled 2004·Application pending·0 cites
- 4237US2008114031A1Monosaccharide derivativesSATTIGERI VISWAJANANI J·Filed 2007·Application pending·0 cites
- 4337US2008255188A1Muscarinic Receptor AntagonistsKUMAR NARESH·Filed 2006·Application pending·0 cites
- 4437US2010113371A9Derivatives Of Pentose Monosaccharides As Anti-Inflammatory CompoundsRANBAXY LAB LTD INC·Filed 2005·Application pending·0 cites
- 4536US6900296B2Cost effective method for selective methylation of erythromycin A derivativesRANBAXY LAB LTD·Filed 2001·Granted May 31, 2005·0 cites·11 claims
- 4636US2009131410A13-azabicyclooctane derivatives as muscarinic receptor antagonistsKUMAR NARESH·Filed 2006·Application pending·0 cites
- 4736US2008280883A1Muscarinic Receptor AntagonistsSALMAN MOHAMMAD·Filed 2005·Application pending·0 cites
- 4836US2005027143A1Process for the preparation of beta-ionylideneacetaldehydeFiled 2002·Application pending·0 cites
- 4936US2005228180A1Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockersSALMAN MOHAMMAD·Filed 2002·Application pending·0 cites
- 5036US2008167317A1Combination TherapyCHUGH ANITA·Filed 2004·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →